Literature DB >> 26909138

Rectal neuroendocrine tumor with uncommon metastatic spread: A case report and review of literature.

Nikolaos Tsoukalas1, Michail Galanopoulos1, Maria Tolia1, Maria Kiakou1, Georgios Nakos1, Aristoula Papakostidi1, Georgios Koumakis1.   

Abstract

Neuroendocrine tumors of the gastrointestinal tract are rare neoplasms. Rectal neuroendocrine tumors consist approximately the 5%-14% of all neuroendocrine neoplasms in Europe. These tumors are diagnosed in relatively young patients, with a mean age at diagnosis of 56 years. Distant metastases from rectal neuroendocrine tumors are not very common. Herein we describe a case of a rectal neuroendocrine tumor which metastasized to the lung, mediastinum and orbit. This case underscores the importance of early identification and optimal management to improve patient's prognosis. Therefore, the clinical significance of this case is the necessity of physicians' awareness and education regarding neuroendocrine tumors' diagnosis and management.

Entities:  

Keywords:  Neuroendocrine tumor; Rectal neuroendocrine neoplasm; Rectal neuroendocrine tumor; Rectum; Uncommon metastatic spread

Year:  2016        PMID: 26909138      PMCID: PMC4753174          DOI: 10.4251/wjgo.v8.i2.231

Source DB:  PubMed          Journal:  World J Gastrointest Oncol


  11 in total

1.  Consensus guidelines for the management of patients with digestive neuroendocrine tumours: well-differentiated colon and rectum tumour/carcinoma.

Authors:  John K Ramage; Peter E Goretzki; Riccardo Manfredi; Paul Komminoth; Diego Ferone; Rudolf Hyrdel; Gregory Kaltsas; Fahrettin Kelestimur; Larry Kvols; Jean-Yves Scoazec; M I Sevilla Garcia; Martyn E Caplin
Journal:  Neuroendocrinology       Date:  2007-11-21       Impact factor: 4.914

2.  Neuroendocrine gastro-entero-pancreatic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  K Öberg; U Knigge; D Kwekkeboom; A Perren
Journal:  Ann Oncol       Date:  2012-10       Impact factor: 32.976

Review 3.  Endocrine tumours of the gastrointestinal tract. Peptide receptor radionuclide therapy.

Authors:  Jaap J M Teunissen; Dik J Kwekkeboom; Marion de Jong; Jan-Paul Esser; Roelf Valkema; Eric P Krenning
Journal:  Best Pract Res Clin Gastroenterol       Date:  2005-08       Impact factor: 3.043

4.  Stage-dependent therapy of rectal carcinoid tumors.

Authors:  M Schindl; B Niederle; M Häfner; B Teleky; F Längle; K Kaserer; R Schöfl
Journal:  World J Surg       Date:  1998-06       Impact factor: 3.352

5.  Carcinoid tumors of the colon. A study of 72 patients.

Authors:  J M Rosenberg; J P Welch
Journal:  Am J Surg       Date:  1985-06       Impact factor: 2.565

Review 6.  Temozolomide in Advanced Neuroendocrine Neoplasms: Pharmacological and Clinical Aspects.

Authors:  Anna Koumarianou; Gregory Kaltsas; Matthew H Kulke; Kjell Oberg; Jonathan R Strosberg; Francesca Spada; Salvatore Galdy; Massimo Barberis; Caterina Fumagalli; Alfredo Berruti; Nicola Fazio
Journal:  Neuroendocrinology       Date:  2015-04-29       Impact factor: 4.914

7.  Neuroendocrine tumor metastatic to the orbit treated with radiotherapy.

Authors:  Renata D'Alpino Peixoto; Howard John Lim; Winson Y Cheung
Journal:  World J Gastrointest Oncol       Date:  2013-08-15

Review 8.  Orbital carcinoid metastases.

Authors:  Jodhbir S Mehta; Yassir Abou-Rayyah; Geoffrey E Rose
Journal:  Ophthalmology       Date:  2006-02-03       Impact factor: 12.079

9.  Neuroendocrine carcinoma of the colon. Correct diagnosis is important.

Authors:  S R Simon; K Fox
Journal:  J Clin Gastroenterol       Date:  1993-12       Impact factor: 3.062

10.  Neuroendocrine cancers of the colon and rectum. Results of a ten-year experience.

Authors:  T J Saclarides; D Szeluga; E D Staren
Journal:  Dis Colon Rectum       Date:  1994-07       Impact factor: 4.585

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.